ARCHIVES

FDA Approves Evista for Breast Cancer Risk Reduction.

This article is from The Cancer Letter archive.

Vol. 33 No. 33 | September 14, 2007

Download PDF Visit The Full Archive

Related Articles

McGivney Out at NCCN as Board Cites Management Style, Strategic Direction

January 13, 2012

NSABP Executive Committee Nominates Wolmark To Succeed Fisher As Chairman

October 21, 1994

Prostatectomy Improves Outcome In Some Men

August 29, 2008

Durant Suggests Six Efforts Needed For Survival Of Clinical Research

May 30, 1986

NCA To Hear Centers’ Reaction, Other Subcommittee, Scientific Reports

November 11, 1977

NCI subsidy of $2 million paid major expenses of rescheduled meeting.

April 15, 2005